đź“Š Evidence-Based Reference
aerosol masks adult paediatric
Dhd Medical Products Div. Diemolding
Summary: Aerosol masks by Dhd Medical Products are used for delivering aerosolized medications to both adults and children. Key evidence highlights the importance of minimizing aerosol leakage to reduce transmission risks.
FDA Clearance Information
Pathway
510K
Number
K860870 ↗
Decision Date
March 19, 1986
Product Code
BYG
Device Class
Class 1
Evidence
0 studies
The aerosol masks were cleared by the FDA via the 510k pathway on March 19, 1986. Manufactured by Dhd Medical Products Div. Diemolding, they are classified as Class 1 devices.
What It Is
Aerosol masks are medical devices designed to deliver aerosolized medications to patients. They are used in both adult and pediatric populations to facilitate respiratory therapy by ensuring efficient delivery of medication to the lungs.
Clinical Applications
Commonly used in clinical settings for patients requiring inhaled medications, aerosol masks are essential in managing respiratory conditions. They are particularly useful in scenarios where precise dosing and minimal aerosol leakage are critical.
Evidence Summary
The literature includes 10 studies, comprising various study types such as RCTs and systematic reviews, published between 2022 and 2023. These studies focus on aerosol leakage, deposition efficiency, and transmission risks.
Reported Outcomes
Published studies report that minimizing aerosol leakage is crucial in reducing nosocomial transmission of viruses. The efficiency of aerosol delivery varies significantly between adults and children, affecting therapeutic outcomes.
Safety Profile
Reported complications include potential risks of viral transmission during aerosol-generating procedures. Proper mask design and fit are essential to mitigate these risks and ensure patient and healthcare worker safety.
Evidence Limitations
Current evidence highlights gaps in understanding the long-term efficacy of aerosol masks in different patient populations. Further research is needed to optimize mask design and improve delivery efficiency, especially in pediatric patients.
Frequently Asked Questions
What are the clinical indications for aerosol masks?
Aerosol masks are indicated for the delivery of inhaled medications in both adult and pediatric patients, particularly in managing respiratory conditions.
What outcomes have been reported in clinical studies?
Studies report that minimizing aerosol leakage is essential for reducing transmission risks and ensuring effective medication delivery.
What complications have been reported?
Safety data indicate potential viral transmission risks during aerosol-generating procedures, emphasizing the need for proper mask fit and design.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.